Organicell Regenerative Medicine Information

Organicell Regenerative Medicine, Inc. (OTCQB:OCEL) is a South Florida-based clinical-stage biopharmaceutical company principally focusing on the development of innovative biological therapeutics for the treatment of chronic diseases and the provision of related services. Our mission is to transform medicine by developing novel regenerative biologic therapies and nano-technologies to address a broad range of medical conditions. Organicell’s proprietary products are derived from perinatal sources and are manufactured to retain the naturally occurring bioactive exosomes, hyaluronic acid, and proteins without the addition or combination of any other substance or diluent.